Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,892 | -13,967 | -4,613 | -12,757 | -9,442 |
| Depreciation Amortization | 83 | 55 | 28 | N/A | 14 |
| Accounts receivable | 13 | 13 | 10 | -60 | 26 |
| Other Working Capital | -390 | -258 | -11 | -1,258 | 935 |
| Other Operating Activity | 6,354 | 4,813 | 1,226 | 1,825 | 1,368 |
| Operating Cash Flow | $-12,832 | $-9,344 | $-3,361 | $-12,250 | $-7,099 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 201 | 201 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $201 | $201 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,888 | -3,888 | -3,888 | -2,809 | -2,085 |
| Common Stock Issued | 249 | 248 | 228 | 36,000 | N/A |
| Common Stock Repurchased | 81 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -436 | -406 | -376 | 17,373 | -953 |
| Financing Cash Flow | $-3,994 | $-4,046 | $-4,036 | $50,564 | $-3,039 |
| Exchange Rate Effect | -14 | -19 | 9 | -22 | -18 |
| Beginning Cash Position | 53,323 | 53,323 | 53,323 | 14,829 | 14,829 |
| End Cash Position | 36,482 | 39,914 | 45,934 | 53,323 | 4,874 |
| Net Cash Flow | $-16,841 | $-13,409 | $-7,388 | $38,494 | $-9,955 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,832 | -9,344 | -3,361 | -12,250 | -7,099 |
| Free Cash Flow | -12,832 | -9,344 | -3,361 | -12,250 | -7,099 |